MHI Receives Follow-up Order for 8 Two-Car Trains for Singapore's Sengkang-Punggol LRT (SPLRT)GuruFocus · Oct 8, 2026
Monte Rosa's MRT-8102 Shows Biomarker Gains in GFORCE-1 StudyMarketBeat · Oct 6, 2026
Monte Rosa Therapeutics Announces Positive Results for MRT-8102 in GFORCE-1 Phase 1 Study Showing Normalization of Key Pathogenic Drivers of ASCVD in Subjects with Elevated CVD RiskGlobeNewsWire · Oct 1, 2026
Monte Rosa Therapeutics to Present Results of MRT-8102 GFORCE-1 Phase 1 Study in Subjects with Elevated Cardiovascular Disease RiskGlobeNewsWire · Sep 30, 2026
Marti Increases Share Repurchase Authorization to $5 Million and Extends Program Through April 2027Business Wire · Sep 10, 2026
Monte Rosa Therapeutics Announces Milestone Achievement Associated with Initiation of Phase 2 Clinical Study for VAV1-directed Molecular Glue Degrader MRT-6160 (DDY391)GlobeNewsWire · Sep 8, 2026Marti Technologies Inc. (MRT), headquartered in Istanbul, Turkey, specializes in urban mobility. The company provides city-dwellers across Turkey with a range of transportation solutions via its proprietary mobile application. This platform offers access to a diverse fleet of shared electric vehicles, including e-mopeds, e-bikes, and e-scooters.
| Date | Est. | Actual | |
|---|---|---|---|
| Aug 19, 2026 | -$0.07 | -$0.15 | Miss |
| May 21, 2026 | -$0.35 | -$0.09 | Beat |
| Apr 13, 2026 | -$0.29 | -$0.29 | Beat |
| Sep 29, 2025 | -$0.31 | -$0.13 | Beat |
| Sep 22, 2025 | -$0.31 | -$0.29 | Beat |
| Apr 29, 2025 | -$0.37 | -$0.88 | Miss |